In vitro preparation of mesenchymal stem cells for clinical studies

ZHANG Wen-cheng,WANG Yun-fang,CHANG Ming-yang,CHI Mu-gen,WANG Hua,LIU Yin-xia,QIN Jin-hua,YAN Fang,PEI Xue-tao,WU Zu-ze

DOI: https://doi.org/10.3969/cmba.j.issn.1673-713X.2012.05.002

2012-01-01

Abstract:Objective To establish a safe, effective and extendable strategy for in vitro preparation of mesenchymal stem cells (MSCs) for clinical studies. Methods UC-MSCs were mechanically isolated from umbilical cord of healthy newborns. After stably proliferating in the medium supplement with new born calf serum named SYL-NBCS through passage1(P 1 ) to P 3 , cells were maintained in serum free medium named SYL-SF from P 4 on with the cells cultured in the SYL-NBCS as control. Cell morphology of UC-MSCs cultured in different medium was observed by inverted microscope and the proliferation was analyzed with CCK-8 test. BSA residues were detected in both cell lysates and supernatant.Results UC-MSCs (P 1 -P 3 ) reached 90% confluence after 3.5 ~ 4 days of culture in SYL-NBCS CCK8 analysis showed that UC-MSCs proliferation rate was similar when they were cultured in either SYL-SF or SYL-NBCS. Furthuremore, BSA residues testing demondtrated that the residuals of BSA in both cell lysate and culture supernatant cultured in SYL-SF were below 10 ng/10 6 cells, which met the safety value as Requirements of Biological Products. Conclusion The sequential culture of MSCs in serum-containing and serum-free culture medium provides a procedural amplification system for sufficient and quality controllable MSCs for either clinical studies or commercial applications.